Oncology clinic in White Bear Lake, Minnesota

IGF Oncology, located at 429 Birchwood Courts in White Bear Lake, Minnesota, is a pioneering institution focused on developing innovative cancer drugs with improved efficacy and reduced side effects compared to traditional chemotherapy treatments. Their lead drug, IGF-MTX, has shown to be 15 times more effective than methotrexate in animal studies, with significantly lower side effects. This drug has completed a Phase 1 study in advanced solid tumors, demonstrating effectiveness even in heavily pre-treated patients. IGF-MTX is currently in a clinical trial at the Mayo Clinic for myelodysplastic syndrome, with promising early results. In addition to their lead drug, IGF Oncology has a pipeline of targeted cancer drugs in development. Registered in Delaware, IGF Oncology, LLC is a cutting-edge institution at the forefront of cancer research and treatment.